If you enjoyed this talk, consider joining the Molecular Modeling and Drug Discovery (M2D2) talks live: https://valence-discovery.github.io/M... 

Also consider joining the M2D2 Slack: https://m2d2group.slack.com/join/shar...

Abstract: High-throughput drug sensitivity experiments in cancer enable rapid in-vitro testing of various compounds on cancer cell lines, or patient-derived material, in order to determine the efficacy of a certain treatment. Accurate prediction of dose-response functions from a limited set of pre-clinical experiments is key to explore the large space of possible treatment options, or to prioritize which experiments to perform. This is particularly important when predicting the effect of drug combinations, where it is unfeasible to test all possible combinations...

Speakers: Leiv Rønneberg - https://twitter.com/ltronneberg 

Twitter Prudencio: https://twitter.com/tossouprudencio

Twitter Therence: https://twitter.com/Therence_mtl 

Twitter Cas: https://twitter.com/cas_wognum 

Twitter Valence Discovery: https://twitter.com/valence_ai